TSS
CATX icon

Two Sigma Securities’s Perspective Therapeutics CATX Stock Holding History

Two Sigma Securities’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,415
Closed -$16.8K – 3031
2024
Q1 		$16.8K Buy
+1,415
New +$12.1K ﹤0.01% 2692
2023
Q4 		– Sell
-7,657
Closed -$21K – 3062
2023
Q3 		$21K Sell
7,657
-2,420
-24% -$11.3K ﹤0.01% 2564
2023
Q2 		$67.3K Buy
+10,077
New +$61.2K ﹤0.01% 2364
2023
Q1 		– Sell
-1,633
Closed -$4.03K – 2702
2022
Q4 		$4.03K Buy
+1,633
New +$5.38K ﹤0.01% 2471
2022
Q3 		– Sell
-3,173
Closed -$10K – 2637
2022
Q2 		$10K Buy
+3,173
New +$9.69K ﹤0.01% 2048
2019
Q3 		– Sell
-6,013
Closed -$25K – 2078
2019
Q2 		$25K Buy
+6,013
New +$25.2K ﹤0.01% 1930
2018
Q1 		– Sell
-5,747
Closed -$23K – 2682
2017
Q4 		$23K Buy
+5,747
New +$26.8K ﹤0.01% 1616
2017
Q3 		– Sell
-1,993
Closed -$12K – 947
2017
Q2 		$12K Sell
1,993
-1,228
-38% -$6.95K ﹤0.01% 803
2017
Q1 		$19K Buy
+3,221
New +$18.9K ﹤0.01% 845

Other funds holding CATX

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Securities's CATX Position: Q2 2024 in Review

Two Sigma Securities sold out of Perspective Therapeutics (CATX) in Q2 2024, closing a stake of 1,415 shares — an estimated $16.8K sold.

Two Sigma Securities first reported a position in CATX in Q1 2017 and held it in 9 quarters. The position peaked at $67.3K in Q2 2023. 105 funds tracked by Wall St. Rank hold CATX as of Q2 2024.

  • Two Sigma Securities reported no remaining Perspective Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Securities sold 1,415 Perspective Therapeutics shares in Q2 2024, an estimated $16.8K.
  • Two Sigma Securities first reported a position in Perspective Therapeutics in Q1 2017 and held it in 9 quarters.
  • Two Sigma Securities's Perspective Therapeutics position peaked at $67.3K in Q2 2023.
  • 105 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2024.

Based on Two Sigma Securities's 13F filing for Q2 2024, filed 14 Aug 2024.